Michael J. Farrell

Michael J. Farrell

Chief executive officeratResmed· In proxies 2023–2026

Pay in FY2026+10% from the year before

Michael J. Farrell was paid $16.2M in FY2026 (Jun), up 10%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Resmed proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ResmedPublic company · 2 yr
    • Chief executive officer2024 – Present · 2 yrNo stock prices for these years
  2. Zimmer Biomet HoldingsPublic company · 3 yr
    • Lead Independent Director2023 – Present · 3 yrNo stock prices for these years
  3. Zimmer Biomet (NYSE: ZBH), a global provider of implantable musculoskeletal medical devices, and associated robotics and digital health technologyPublic company · 12 yr
    • Director2014 – Present · 12 yrNo stock prices for these years
  4. LeadPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Zimmer Biomet HoldingsLead independent director · 11 yr on the boardIndependentCompensation and Management Development, Quality, Regulatory and Technology—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?